Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor

Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor

US Patent 11026914 · Granted Jun 8, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic benefit of suboptimally administered chemical compounds2025
Compositions and methods to improve the therapeutic benefit of suboptimally admi2025
Methods for sub-austenite transformation temperature deposition of inorganic par2024
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 a2024
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas2023
Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas2023
Compositions and methods for detecting and/or treating inflammation2023
Use of dianhydrogalactitol and analogs or derivatives thereof in combination wit2023
Use of dianhydrogalactitol and analogs or derivatives thereof in combination wit2023
Therapeutic benefit of suboptimally administered chemical compounds2022
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pe2022
Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pe2022